Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Hip, Knee Replacement Infection Lawsuits Over 3M Bair Hugger Claim HEPA Non-Compliance August 21, 2015 Irvin Jackson Add Your Comments 3M and their Arizant Healthcare subsidiary face a growing number of product liability lawsuits over hip and knee replacement infections caused by Bair Hugger warming blankets, which allege that the manufacturers lied to the FDA about how effective the forced air warming device is at filtering out contaminants. The Bair Hugger has been commonly used during most orthopedic joint replacement procedures in recent years, providing forced air warming (FAW) to help control the patient’s body temperature during surgery. However, many patients are now pursuing hip replacement infection lawsuits and knee replacement infection lawsuits, claiming that the device caused bacteria and contaminants from the operating room floor to enter the sterile surgical field. More than 50,000 Bair Hugger units are in hospitals nationwide, and the warming blankets have been used on millions of patients. The lawsuits claim that the manufacturer has known about the infection risk for years, yet failed to make design changes or provide warnings to the medical community. Learn More About Knee and Hip Surgery Infection Lawsuits Bair Hugger warming blankets may be the cause of knee or hip surgery infections. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Knee and Hip Surgery Infection Lawsuits Bair Hugger warming blankets may be the cause of knee or hip surgery infections. Learn More SEE IF YOU QUALIFY FOR COMPENSATION At least four Bair Hugger lawsuits were filed this week, alleging that Arizant, the original creator of the forced air warming blanket that was later acquired by 3M, provided false and misleading information to the FDA in 2000 about the effectiveness of the device in filtering air particles. High Efficiency Particulate Air (HEPA) standards require that an air filter be capable of removing 99.97% of all particles 0.3 microns or larger. However, plaintiffs allege that the manufacturer told the FDA that the Bair Hugger meets this standard, when it does not, causing hip and knee replacement patients to face a risk of serious infection during the procedure. According to allegations raised in one complaint (PDF) filed in the U.S. District Court for the District of Minnesota on August 19, the Bair Hugger blanket caused an Alabama woman, Barbara Libby, to suffer a severe infection following a right hip replacement procedure in November 2010. “The filter of the Bair Hugger, which is marketed as HEPA compliant, is only capable of removing less than 65% of all such particles,” according to the lawsuit filed by Libby. “When the Defendants made these representations, they had actual knowledge of their falsity.” The lawsuit also notes that as early as 1997, the manufacturer admitted to the FDA that “air blown intraoperatively across the surgical wound may result in airborne contamination.” They told the FDA that was prevented in the case of the Bair Hugger by a tape barrier, which plaintiffs say does not work Libby claims that the forced air warmer introduced contaminants into her surgical wound, resulting in the need for seven additional surgeries, including one to remove the implant. She has now been left with permanent injuries and impaired mobility, requiring use of a cane or walker to walk. Similar allegations were raised in another complaint (PDF) filed the same day in the District of Minnesota, where Michael Williams claims that he experienced an infection following a right knee replacement surgery in February 2013, where a Bair Hugger warming blanket was used. Due to the infection, Williams required two additional surgeries within less than nine months of the implant, the first to remove the artificial knee and place a temporary antibiotic spacer. Months later, he underwent a second procedure to remove the spacer and place another knee implant. “The Defendants concealed and continue to conceal their knowledge of the Bair Hugger’s unreasonably dangerous risks from Plaintiff, other consumers, and the medical community,” according to the lawsuit filed by Williams. “The defendants failed to conduct adequate and sufficient post-marketing surveillance after they began marketing, advertising, distributing and selling the Bair Hugger.” As more individuals discover the potential link between their knee or hip replacement infection and the Bair Hugger warming blanket, it is expected that the number of complaints will continue to increase over the coming months or years. Plaintiffs are pursuing claims for failure to warn, designing and manufacturing a defective product, breach of warranty, negligent misrepresentation, fraudulent misrepresentation, and fraudulent concealment, seeking both punitive and compensatory damages. Tags: 3M Company, Arizant Healthcare, Bair Hugger, Forced Air Warming, Hip Replacement, Infection, Knee Replacement, Minnesota Image Credit: | More Bair Hugger Lawsuit Stories 3M Seeks Dismissal of More Than 100 Bair Hugger Infection Lawsuits March 11, 2025 Supreme Court Rejects 3M Appeal Over Surgical Warming Blanket Infection Lawsuit May 17, 2022 Supreme Court Review Sought For 3M Bair Hugger Appeal February 10, 2022 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: yesterday) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)